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Poster Session II S385identified from the departmental database for comparison.Mobilisa-
tion chemotherapy in all patients consisted of Cyclophosphamide
2gm/m2. Those given conventional subcutaneous GCSF (Group 1)
started 5mcg/kg daily (rounded to vial size) on the day after cyclo-
phosphamide and continued until mobilisation was complete. Those
given subcutaneous Pegylated G-CSF (Group 2) were given a single
6mcg dose 24 hours post chemotherapy. Harvest was deemed suc-
cessful if the CD34 cell count in product was . 2.0 x 106/kg. Data
collected included product CD34 count, peripheral blood white
cell count, CD34 count and CD34%, time (days) until harvest, num-
ber of apheresis, and the number of conventional GCSF doses ad-
ministered.
Results: Forty four patients (22 in each group) mobilised between
04/08/2008 and 26/04/2011 were identified. 29 were male and 15
were female with a median age of 60 years. There was no difference
in mobilisation success (95% in both groups) with a median CD34
count of 4.7 x106/kg in Group 1 and 4.8 x 106/kg in Group 2 (p 5
0.9). The median time to first apheresis procedure was 9 days in
each group. Six patients in group 1 required a second day of apheresis,
comparedwith 4 patients in group 2. Patients in group1 received ame-
dian of 8 doses of GCSF compared with one dose in group 2.
Conclusions: Pegylated GCSF gives similar PBSC mobilisation
success compared with conventional daily GCSF when used with cy-
clophosphamide in patients with myeloma.This represents a cost
saving with one Pegylated G-CSF 6mg being the cost equivilent to
5 doses of conventional G-CSF.
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Besien, K.2 1University of Chicago Medical Center, Chicago, IL; 2Weill
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Allogeneic hematopoietic cell transplantation (HCT) is a complex
treatment which can be both life-saving and life-threatening. Excel-
lent general resources exist to educate patients such as the National
MarrowDonor Program (NMDP) and the BoneMarrowTransplant
Infonet.However,we found that patients and their families coming to
transplant continued to have fears and uncertainties about specific
transplant details and logistics not addressed.
We developed the ‘‘Allogeneic Stem Cell Transplant Patient
Guide’’ in 2009 with input across transplant teammembers and pro-
vided the booklet to all allogeneic transplant recipients. The booklet
contains both general information as well as center specific informa-
tion on the domains: stem cell transplantation overview, identifying
a donor, participation in research studies, preparing for hospitaliza-
tion, conditioning, preparing for the recovery phase and discharge,
GVHD, infections, immunosuppressant and antimicrobial medica-
tions, long-term effects after transplant, and further resources for in-
formation and support.
To evaluate the utility of the Patient Guide, we prepared a survey
instrument with responses rated from 1 to 5, where 1 was low and 5
was high. We sent surveys to 60 patients who were transplanted be-
tween April 2010 and September 2011. Of these 60 patients, 4 were
too ill to complete the survey. Twenty eight (50% response rate) sur-
veys were returned. Most patients had some knowledge about trans-
plantation but all responders felt their knowledge had positively
changed after reading the book. The patients found the guide was
useful in preparing them for the transplant process and was clear
and easy to understand as depicted in table 1.
Table 1. N 5 28
Question related to Patient Guide Mean SDKnowledge before guide 2.29 1.03
Increased knowledge about
transplantation after guide
4.18 0.68Guide useful in preparing for
hospitalization4.13 1.07Guide useful in preparing for home
care after transplant4.35 0.75Information easy to understand 4.55 0.57Our center specific educational guide successfully informed pa-
tients about the specific transplant process at our center. In the fu-
ture, we believe internet based resources will provide better and
updated information.495
RETENTION AND SATISFACTION ON BMT: AN EVIDENCE-BASED PRAC-
TICE PROJECT
Morrison, C.F. Cincinnati Children’s Hospital Medical Center, Cincin-
nati, OH
Background:Registered nurse (RN) turnover represents a signifi-
cant cost to the institution, as well as a burden to the remaining
staff in training and replacing the RN. Bone marrow transplant
(BMT) staff are constantly engaged in providing a therapeutic
presence to support families and meet their needs throughout
the transplant process. This process is intense and complex med-
ically, emotionally, socially and spiritually for the families and the
staff that care for them. Work-related stress on the BMT unit
impacts nurse retention, job satisfaction, and quality of care.
Clinical Question: Among pediatric registered nurses in high acu-
ity inpatient setting does having a staff psycho-social support pro-
gram versus no support program, increase staff satisfaction?
Increased staff satisfaction defined: decreased burnout, increased
morale, increased retention, decreased turnover. Larrabee’s
(2009) Model of Evidence-Based Practice Change was used to
guide this evidence-based practice project.
Evidence Appraisal: Search terms: job satisfaction, compassion fa-
tigue, critical care, nursing, reflective supervision, secondary trauma-
tization, support program, mentorship, burnout, Bone Marrow
Transplant. Databases:MEDLINE, CINAHL, PsycINFO, andCo-
chrane. Search limits: articles printed in English. Questions sent to
Listservs with little response.
Synthesis of Evidence: One expert opinion and two descriptive
were applicable to the clinical question. Two of these studies de-
scribe a program and found the staff had low burnout and high job
satisfaction (Sarantos, 1988 [5a], Molassiotis & Haberman, 1996
[4a]). The overall grade of the evidence was low. Three interventions
in the literature could be incorporated into a support program: men-
toring, grief support, and education on coping (Aycock & Boyle,
2009 [4a]).
Recommendations: There is insufficient evidence and lack of con-
sensus in the literature. Recommend further research.
Implementation/Evaluation:A qualitative study using Madeleine
Leininger’s Theory of Culture Care and Universality will be im-
plemented on BMT pending IRB approval. Focus groups of
RNs, medical team, families, and support staff will be conducted.
Transcripts will be analyzed for themes and an intervention will
be designed to address the themes that emerge from the research.
Internal data is also being collected on staff satisfaction and
turnover.
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PROMOTING PATIENT SELF-CARE ACROSS THE CONTINUUM
Elchook, A.M. Duke University Hospital, Durham, NC
In the Adult Bone Marrow transplant setting, patients are given
a great volume of information regarding the transplant process,med-
ications, and basic care needs that are essential to their successful
transplant. As learning needs change for patients it is critical to un-
derstand which education points need to be highlighted more fre-
quently. We implemented a behavior reinforcement tool on the
inpatient transplant unit designed to put the patient in charge of their
daily care needs such as mouth care, exercise, nutrition, etc. By insti-
tuting this tool on the inpatient unit, we hope patients will start to
realize the importance of continuing these daily self-care needs in
the outpatient setting when they are under less supervision by a for-
mal caregiving staff, have more autonomy, and more supervision by
informal caregivers. We also implemented an ‘additional focus for
today’ section to write what needs to be re-educated based on the in-
dividual patient. The sheets are displayed on each patient’s bulletin
